ArticleOncoTargets and therapy2019
CD48 is a key molecule of immunomodulation affecting prognosis in glioma.
Cunyi Zou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it
ArticleOncoTargets and therapy2019
Cunyi Zou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.